Skip to content
OpenCapital
Get started

West Pharmaceutical Services WST Equity Method Investments

Equity Method Investments at other companies

AptarGroup logo
AptarGroupATR
$130.76M-11.5%
Dow logo
DowDOW
$224M+50.3%
UFP Technologies logo
UFP TechnologiesUFPT
$6.89M+0.6%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$209.72M-2.0%
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
——

Other financials

Income statement

See full
Revenue$844.9M+21.0%
Gross profit$296.4M+27.8%
Operating income$177.1M+65.5%
Net income$138.8M+54.6%
EPS (diluted)$1.92+56.1%

Balance sheet

See full
Cash & equivalents$521.4M+29.0%
Total debt$321.0M+4.4%
Total equity$3.0B+11.5%
Total assets$4.1B+13.6%

Cash flow

See full
Operating cash flow$89.9M-30.5%
CapEx$42.7M-40.1%
Free cash flow$47.2M-18.8%

Valuation

See full
Market cap$25.36B+64.2%
Enterprise value$25.16B+65.1%
P/E46.7×+15.1×
P/S7.9×+2.7×

Profitability

See full
Gross margin36.3%+1.7pp
Operating margin20.3%+1.2pp
Net margin16.8%+0.7pp
FCF margin14.2%+3.6pp

Returns & leverage

See full
Return on equity19.1%+1.7pp
Debt / equity0.1×0.0×
Current ratio2.7×-0.1×

Where this comes from

Reported directly by West Pharmaceutical Services in its filing.

Tagged under the XBRL concept us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures.

The official record: West Pharmaceutical Services’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about West Pharmaceutical Services's equity method investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is West Pharmaceutical Services's equity method investments?
West Pharmaceutical Services (WST) reported equity method investments of $209.2M in Q1 2026.
How has West Pharmaceutical Services's equity method investments changed year-over-year?
West Pharmaceutical Services's equity method investments decreased by 1.3% year-over-year, from $211.9M to $209.2M.
What is the long-term trend for West Pharmaceutical Services's equity method investments?
Over 5 years (2020 to 2025), West Pharmaceutical Services's equity method investments has grown at a -0.2% compound annual growth rate (CAGR), from $214.7M to $212.3M.
What does equity method investments mean?
Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.